rupiya.io
⠋Loading sector...
0%
❯ Mapping sector landscape...
Specialty exposure and domestic chronic therapy share remain the main margin moats in Indian pharma.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹4,51,075 Cr | ₹1,891.3 | 41.3 | 5.8 | 0.0% | 25.1% | 0.1 | 0.9% | +8.45% |
| Dr Reddys Laboratories Ltd | ₹1,11,310 Cr | ₹1,318.5 | 19.7 | 3.0 | 11.8% | 20.7% | 0.2 | 0.6% | +8.74% |
| Cipla Ltd | ₹1,15,638 Cr | ₹1,401.9 | 25.5 | 3.5 | 11.7% | 24.0% | 0.0 | 0.9% | -5.78% |
| Apollo Hospitals Enterprise Ltd | ₹1,16,201 Cr | ₹8,308.5 | 64.5 | 12.8 | 0.0% | 25.7% | 0.8 | 0.3% | +7.74% |
| Divis Laboratories Ltd | ₹1,79,486 Cr | ₹6,858 | 72.5 | 11.6 | 0.0% | 19.7% | 0.0 | 0.0% | +3.69% |
| Torrent Pharmaceuticals Ltd | ₹1,49,446 Cr | ₹4,469.2 | 69.7 | 17.7 | 0.0% | 28.6% | 0.3 | 0.8% | +15.25% |
| Max Healthcare Institute Ltd | ₹1,02,191 Cr | ₹1,091.1 | 72.5 | 10.2 | 0.0% | 24.5% | 0.3 | 0.0% | -4.83% |
| Zydus Lifesciences Ltd | ₹1,01,755 Cr | ₹1,036.45 | 20.6 | 4.0 | 0.0% | 22.1% | 0.3 | 0.0% | +6.36% |
| 3B BlackBio Dx Ltd | ₹1,178 Cr | ₹1,201.8 | 0.0 | 3.9 | 533.3% | 0.0% | 0.0 | 0.0% | -15.3% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹258 Cr | ₹82.03 | 74.6 | 1.7 | 0.0% | 0.7% | 0.4 | 0.0% | -8.65% |
| Aarti Drugs Ltd | ₹3,340 Cr | ₹380.4 | 16.6 | 2.5 | 13.4% | 12.5% | 0.4 | 0.0% | -22.58% |
| Aarti Pharmalabs Ltd | ₹6,358 Cr | ₹703.5 | 29.8 | 3.1 | 0.0% | 21.2% | 0.3 | 0.6% | -6.28% |
| Abbott India Ltd | ₹58,659 Cr | ₹27,715 | 37.9 | 12.3 | 34.5% | 57.1% | 0.0 | 0.0% | -5.51% |
| Anlon Healthcare Ltd | ₹716 Cr | ₹13.89 | 20.7 | 2.6 | 0.0% | 24.2% | 0.3 | 0.0% | -5.59% |
| Ajanta Pharma Ltd | ₹39,663 Cr | ₹3,149.2 | 39.1 | 9.2 | 25.4% | 59.9% | 0.1 | 0.9% | +23.27% |
| Akums Drugs and Pharmaceuticals Ltd | ₹7,957 Cr | ₹521.35 | 31.2 | 2.4 | 8.0% | 16.8% | 0.1 | 0.0% | +17.81% |
| Albert David Ltd-$ | ₹409 Cr | ₹706.3 | 42.5 | 1.0 | -0.4% | -1.1% | 0.1 | 0.7% | -15.28% |
| Alivus Life Sciences Ltd | ₹12,953 Cr | ₹1,056.5 | 23.0 | 3.9 | 18.4% | 34.9% | 0.0 | 0.0% | +14.34% |
| Alkem Laboratories Ltd | ₹65,211 Cr | ₹5,501.5 | 27.5 | 4.9 | 0.0% | 19.7% | 0.2 | 0.9% | -3.77% |
| Alpa Laboratories Ltd | ₹148 Cr | ₹69.56 | 12.7 | 0.9 | 0.0% | 3.0% | 0.0 | 0.0% | -16.35% |
| Amanta Healthcare Ltd | ₹504 Cr | ₹126.24 | 36.9 | 2.1 | 0.0% | 16.6% | 0.9 | 0.0% | +5.14% |
| Ambalal Sarabhai Enterprises Ltd | ₹0 Cr | ₹32.75 | 24.0 | 1.8 | 0.0% | 7.7% | 0.3 | 0.0% | -14.8% |
| Amrutanjan Health Care Ltd-$ | ₹1,613 Cr | ₹549.25 | 28.3 | 4.4 | 0.0% | 27.1% | 0.0 | 0.0% | -22.26% |
| Anthem Biosciences Ltd | ₹44,010 Cr | ₹769.1 | 91.7 | 16.0 | 0.0% | 32.3% | 0.0 | 0.0% | +15.06% |
| Anuh Pharma Ltd | ₹799 Cr | ₹76.17 | 19.1 | 2.4 | 0.0% | 28.3% | 0.0 | 0.0% | -3.30% |
| Alembic Pharmaceuticals Ltd | ₹14,165 Cr | ₹748.9 | 22.5 | 2.5 | 12.4% | 13.1% | 0.3 | 0.0% | -14.46% |
| Aster DM Healthcare Ltd | ₹38,964 Cr | ₹759.25 | 117.6 | 8.6 | 0.0% | 23.9% | 0.4 | 0.0% | +10.61% |
| AstraZeneca Pharma India Ltd | ₹21,362 Cr | ₹8,589.5 | 106.2 | 26.7 | 0.0% | 156.4% | 0.0 | 0.0% | -7.26% |
| Aurobindo Pharma Ltd | ₹87,910 Cr | ₹1,546.7 | 25.7 | 2.5 | 0.0% | 15.3% | 0.2 | 0.0% | +29.46% |
| Bafna Pharmaceuticals Ltd | ₹319 Cr | ₹135.84 | 32.9 | 3.5 | 0.0% | 131.3% | 0.4 | 0.0% | -14.55% |
| Bajaj Healthcare Ltd | ₹971 Cr | ₹304.45 | 42.8 | 1.7 | 4.3% | 10.2% | 0.5 | 0.6% | -36.74% |
| BALAXI | ₹143 Cr | ₹25.04 | 15.1 | 0.6 | 0.0% | 19.3% | 0.2 | 0.0% | -53.77% |
| Bal Pharma Ltd | ₹126 Cr | ₹85.13 | 15.5 | 1.6 | 0.0% | 10.4% | 2.0 | 0.0% | -1.43% |
| BETA | ₹1,284 Cr | ₹1,237.1 | 19.9 | 2.9 | 0.0% | 37.7% | 0.7 | 0.0% | -31.4% |
| Biocon Ltd | ₹68,635 Cr | ₹430.85 | 149.2 | 2.0 | 1.2% | 4.7% | 0.4 | 0.1% | +5.96% |
| Biofil Chemicals & Pharmaceuticals Ltd | ₹52 Cr | ₹31.55 | 19.0 | 2.5 | 0.0% | 0.0% | 0.0 | 0.0% | -15.88% |
| Bliss GVS Pharma Ltd | ₹3,040 Cr | ₹295.2 | 28.2 | 2.7 | 0.0% | 9.4% | 0.0 | 0.0% | +72.81% |
| Blue Jet Healthcare Ltd | ₹7,304 Cr | ₹439.95 | 24.9 | 5.8 | 0.0% | 32.1% | 0.0 | 0.0% | -25.93% |
| Brooks Laboratories Ltd | ₹138 Cr | ₹51.18 | 6.4 | 1.2 | 0.0% | 0.0% | 0.1 | 0.0% | -55.16% |
| Caplin Point Laboratories Ltd | ₹15,116 Cr | ₹2,025.9 | 23.6 | 4.9 | 0.0% | 32.5% | 0.0 | 0.0% | +2.57% |
| Cohance Lifesciences Ltd | ₹16,225 Cr | ₹419.9 | 90.2 | 4.3 | 0.0% | 20.5% | 0.1 | 0.0% | -38.08% |
| Concord Biotech Ltd | ₹11,771 Cr | ₹1,123.3 | 37.8 | 6.5 | 0.0% | 27.2% | 0.0 | 0.0% | -23.08% |
| Corona Remedies Ltd | ₹10,881 Cr | ₹1,706.4 | 60.3 | 16.9 | 27.4% | 31.4% | 0.2 | 0.4% | +26.54% |
| Dishman Carbogen Amcis Ltd | ₹2,939 Cr | ₹211.88 | 24.7 | 0.5 | 0.0% | 6.2% | 0.4 | 0.0% | -26.88% |
| Dr Agarwals Eye Hospital Ltd-$ | ₹2,452 Cr | ₹5,031.7 | 34.4 | 7.6 | 27.0% | 0.0% | 1.1 | 0.1% | +14.22% |
| Emcure Pharmaceuticals Ltd | ₹31,864 Cr | ₹1,751.5 | 34.5 | 6.4 | 19.6% | 21.7% | 0.3 | 0.2% | +18.11% |
| Entero Healthcare Solutions Ltd | ₹5,186 Cr | ₹1,299.9 | 46.1 | 2.9 | 0.0% | 54.0% | 0.3 | 0.0% | +9.61% |
| Eris Lifesciences Ltd | ₹18,641 Cr | ₹1,385.9 | 42.7 | 5.9 | 0.0% | 13.8% | 0.7 | 0.0% | -15.95% |
| FDC Ltd | ₹5,892 Cr | ₹362.4 | 27.2 | 2.4 | 0.0% | 14.1% | 0.0 | 1.4% | -11.12% |
| Fermenta Biotech Ltd | ₹847 Cr | ₹306.2 | 10.0 | 2.2 | 22.7% | 0.0% | 0.3 | 0.0% | -14.4% |
| Fortis Healthcare Ltd | ₹71,536 Cr | ₹967.3 | 74.5 | 7.6 | 0.0% | 31.9% | 0.3 | 0.0% | -0.74% |
| Gaudium IVF and Women Health Ltd | ₹783 Cr | ₹116.74 | 32.3 | 14.3 | 0.0% | 45.5% | 0.0 | 0.0% | 0.00% |
| Gujarat Kidney and Super Speciality Ltd | ₹1,082 Cr | ₹139.48 | 63.3 | 30.1 | 0.0% | 39.4% | 0.0 | 0.0% | 0.00% |
| Gland Pharma Ltd | ₹35,212 Cr | ₹2,331 | 41.6 | 3.7 | 10.5% | 18.1% | 0.0 | 0.0% | +17.34% |
| GlaxoSmithKline Pharmaceuticals Ltd | ₹41,331 Cr | ₹2,320.7 | 43.3 | 24.2 | 0.0% | 159.4% | 0.0 | 0.0% | -4.63% |
| Glenmark Pharmaceuticals Ltd | ₹65,059 Cr | ₹2,393 | 61.2 | 6.8 | 0.0% | 19.4% | 0.1 | 0.0% | +26.68% |
| GPT Healthcare Ltd | ₹1,163 Cr | ₹140.65 | 28.7 | 4.6 | 0.0% | 32.8% | 0.4 | 1.8% | -2.76% |
| Granules India Ltd-$ | ₹18,041 Cr | ₹764.2 | 29.8 | 3.5 | 13.5% | 15.6% | 0.3 | 0.2% | +34.84% |
| Gufic Biosciences Ltd | ₹2,779 Cr | ₹288.7 | 55.5 | 4.4 | 0.0% | 15.6% | 0.6 | 0.0% | -16.17% |
| Gujarat Themis Biosyn Ltd | ₹3,793 Cr | ₹357.1 | 78.8 | 14.3 | 0.0% | 24.1% | 0.3 | 0.0% | -22.75% |
| Haleos Labs Ltd | ₹471 Cr | ₹1,686.2 | 23.7 | 2.3 | 0.0% | 14.9% | 0.3 | 0.0% | +23.78% |
| HealthCare Global Enterprises Ltd | ₹9,440 Cr | ₹627 | 471.8 | 9.6 | 0.0% | 14.0% | 1.8 | 0.0% | -15.55% |
| Health X Platform Ltd | ₹954 Cr | ₹284.75 | 36.6 | 1.4 | 0.0% | -16.7% | 0.0 | 0.0% | +12.5% |
| Hester Biosciences Ltd | ₹1,560 Cr | ₹1,881.9 | 37.9 | 4.7 | 0.0% | 10.0% | 0.6 | 0.0% | +5.77% |
| Hikal Ltd | ₹2,513 Cr | ₹205.5 | 0.0 | 2.0 | 0.0% | 11.2% | 0.0 | 0.0% | -17.59% |
| Indoco Remedies Ltd | ₹2,074 Cr | ₹204.29 | 0.0 | 1.8 | -10.1% | -1.6% | 1.2 | 0.1% | -19.71% |
| Indraprastha Medical Corporation Ltd | ₹3,301 Cr | ₹355.45 | 18.1 | 5.0 | 0.0% | 39.0% | 0.1 | 0.0% | -34.14% |
| Ind-Swift Laboratories Ltd | ₹1,163 Cr | ₹135.35 | 3.9 | 0.8 | 0.0% | 0.0% | 0.0 | 0.0% | +28.89% |
| Innova Captab Ltd | ₹5,019 Cr | ₹872.25 | 35.6 | 4.9 | 0.0% | 19.9% | 0.3 | 0.0% | +23.54% |
| IOL Chemicals & Pharmaceuticals Ltd | ₹3,183 Cr | ₹121.17 | 27.5 | 1.8 | 0.0% | 8.7% | 0.1 | 0.9% | +10.35% |
| Ipca Laboratories Ltd | ₹40,739 Cr | ₹1,637 | 44.8 | 5.0 | 0.0% | 20.1% | 0.1 | 0.1% | +22.78% |
| Jagsonpal Pharmaceuticals Ltd | ₹1,386 Cr | ₹211.84 | 32.7 | 5.2 | 16.7% | 17.7% | 0.0 | 1.9% | -6.16% |
| JB Chemicals & Pharmaceuticals Ltd | ₹34,337 Cr | ₹2,178.9 | 48.0 | 8.8 | 0.0% | 29.8% | 0.0 | 0.9% | +16.83% |
| Jupiter Life Line Hospitals Ltd | ₹8,773 Cr | ₹1,312 | 46.5 | 6.0 | 13.4% | 37.7% | 0.4 | 0.0% | -11.04% |
| Jeena Sikho Lifecare Ltd | ₹7,848 Cr | ₹654.2 | 37.0 | 22.2 | 0.0% | 57.3% | 0.3 | 0.0% | -15.84% |
| Jubilant Pharmova Ltd | ₹16,043 Cr | ₹1,011.65 | 37.2 | 2.4 | 0.0% | 11.6% | 0.4 | 0.0% | -11.41% |
| Kilitch Drugs India Ltd | ₹610 Cr | ₹183.06 | 22.2 | 2.2 | 12.4% | 17.2% | 0.3 | 0.0% | -7.12% |
| Krishna Institute of Medical Sciences Ltd | ₹28,970 Cr | ₹769.15 | 96.0 | 12.8 | 9.7% | 17.1% | 1.7 | 0.0% | +4.28% |
| Kopran Ltd | ₹832 Cr | ₹167.25 | 50.4 | 1.7 | 0.0% | 16.0% | 0.3 | 0.0% | +9.25% |
| Kovai Medical Center & Hospital Ltd | ₹5,868 Cr | ₹5,398 | 24.9 | 4.9 | 0.0% | 20.2% | 0.3 | 0.0% | -11.29% |
| Kwality Pharmaceuticals Ltd | ₹1,784 Cr | ₹2,087 | 31.5 | 6.2 | 15.8% | 0.0% | 0.4 | 0.0% | +85.79% |
| Krebs Biochemicals & Industries Ltd-$ | ₹125 Cr | ₹56.07 | 0.0 | -0.8 | 0.0% | 0.0% | 0.0 | 0.0% | -20.41% |
| Lasa Supergenerics Ltd | ₹41 Cr | ₹8.1 | 2.2 | 0.7 | 0.0% | -7.1% | 0.1 | 0.0% | -28.44% |
| Laurus Labs Ltd | ₹70,884 Cr | ₹1,351 | 84.0 | 14.8 | 17.7% | 9.8% | 0.5 | 0.0% | +34.18% |
| Lincoln Pharmaceuticals Ltd | ₹1,292 Cr | ₹732.15 | 14.7 | 1.8 | 0.0% | 15.1% | 0.0 | 0.0% | +29.56% |
| Lotus Eye Hospital And Institute Ltd | ₹223 Cr | ₹107.83 | 334.4 | 3.4 | 0.0% | 1.5% | 0.1 | 0.0% | -11.24% |
| Lupin Ltd | ₹1,03,910 Cr | ₹2,284.5 | 24.1 | 5.3 | 26.9% | 24.6% | 0.3 | 0.8% | +10.64% |
| Lyka Labs Ltd | ₹219 Cr | ₹61.27 | 104.2 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | -36.03% |
| Mangalam Drugs & Organics Ltd | ₹48 Cr | ₹30.51 | 0.0 | 0.4 | 0.0% | 8.6% | 0.8 | 0.0% | -51.47% |
| Mankind Pharma Ltd | ₹1,03,368 Cr | ₹2,514.1 | 58.1 | 6.8 | 0.0% | 12.6% | 0.5 | 0.0% | +9.94% |
| Marksans Pharma Ltd | ₹9,862 Cr | ₹216.17 | 27.4 | 3.7 | 0.0% | 35.2% | 0.1 | 0.0% | +10.69% |
| Max India Ltd | ₹823 Cr | ₹157.59 | 0.0 | 1.8 | 0.0% | 0.0% | 0.4 | 0.0% | -23.2% |
| Global Health Ltd | ₹33,168 Cr | ₹1,240.2 | 59.8 | 9.0 | 15.0% | 26.4% | 0.3 | 0.0% | +5.57% |
| Medi Assist Healthcare Services Ltd | ₹2,786 Cr | ₹374.05 | 47.5 | 4.5 | 12.7% | 19.1% | 0.1 | 0.5% | -21.45% |
| Medicamen Biotech Ltd-$ | ₹380 Cr | ₹266.85 | 48.1 | 1.7 | 0.0% | 8.9% | 0.1 | 0.0% | -34.04% |
| Medico Remedies Ltd | ₹365 Cr | ₹47.12 | 31.4 | 5.5 | 0.0% | 16.5% | 0.2 | 0.0% | -16.53% |
| Medplus Health Services Ltd | ₹11,136 Cr | ₹953.9 | 53.9 | 6.0 | 0.0% | 16.0% | 0.7 | 0.0% | +22.11% |
| Morepen Laboratories Ltd | ₹2,299 Cr | ₹42.98 | 23.4 | 1.9 | 0.0% | 24.5% | 0.1 | 0.0% | -12.39% |
| Natural Capsules Ltd | ₹159 Cr | ₹151.72 | 0.0 | 0.7 | 0.0% | 4.7% | 0.5 | 0.0% | -24.47% |
| Natco Pharma Ltd | ₹21,019 Cr | ₹1,174.3 | 13.5 | 2.4 | 0.0% | 30.8% | 0.0 | 0.4% | +41.59% |
| Nectar Lifesciences Ltd | ₹245 Cr | ₹12.21 | 0.0 | 0.4 | 0.0% | -7.6% | 0.6 | 0.0% | -12.63% |
| Nephrocare Health Services Ltd | ₹6,459 Cr | ₹585.45 | 90.9 | 1.7 | 0.0% | 96.0% | 0.4 | 0.0% | 0.00% |
| Neuland Laboratories Ltd | ₹21,003 Cr | ₹16,690 | 57.7 | 11.2 | 0.0% | 25.8% | 0.2 | 0.0% | -7.20% |
| NGL Fine Chem Ltd | ₹1,450 Cr | ₹2,501.9 | 41.0 | 4.8 | 0.0% | 6.3% | 0.3 | 0.0% | +55.88% |
| Narayana Hrudayalaya Ltd | ₹37,287 Cr | ₹1,930.9 | 48.0 | 9.2 | 0.0% | 20.9% | 0.6 | 0.0% | +5.99% |
| Novartis India Ltd | ₹2,917 Cr | ₹1,346.6 | 30.0 | 3.8 | 0.0% | 12.8% | 0.0 | 0.0% | +16.15% |
| Onesource Specialty Pharma Ltd | ₹21,183 Cr | ₹1,861.8 | 0.0 | 3.6 | 0.0% | 0.0% | 0.2 | 0.0% | +3.04% |
| Orchid Pharma Ltd | ₹3,617 Cr | ₹707.55 | 188.6 | 2.9 | 0.0% | 0.0% | 0.0 | 0.0% | -11.54% |
| Ortin Global Ltd | ₹11 Cr | ₹15.6 | 0.0 | 8.6 | 0.0% | -74.4% | 0.7 | 0.0% | +19.8% |
| Panacea Biotec Ltd | ₹2,370 Cr | ₹424.3 | 0.0 | 2.9 | 0.0% | -7.7% | 0.0 | 0.0% | +1.74% |
| PAR | ₹107 Cr | ₹83.27 | 7.7 | 1.0 | 0.0% | 25.9% | 0.0 | 0.0% | -7.09% |
| Park Medi World Ltd | ₹10,356 Cr | ₹255.76 | 34.9 | 4.7 | 16.9% | 20.5% | 0.2 | 0.0% | +47.99% |
| Pfizer Ltd | ₹22,262 Cr | ₹4,651.3 | 30.8 | 5.8 | 17.2% | 32.5% | 0.0 | 1.5% | -3.11% |
| Procter & Gamble Health Ltd | ₹8,723 Cr | ₹5,455 | 36.9 | 14.1 | 0.0% | 0.0% | 0.0 | 0.0% | -11.62% |
| Piramal Pharma Ltd | ₹23,064 Cr | ₹176.08 | 0.0 | 2.9 | -4.0% | 0.7% | 0.7 | 0.0% | -10.49% |
| Rainbow Children's Medicare Ltd | ₹13,708 Cr | ₹1,344.8 | 53.5 | 9.0 | 0.0% | 19.8% | 0.5 | 0.0% | -0.57% |
| RPG Life Sciences Ltd | ₹3,805 Cr | ₹2,274.2 | 18.8 | 6.3 | 20.3% | 30.6% | 0.0 | 1.1% | -2.06% |
| Rubicon Research Ltd | ₹15,832 Cr | ₹969.1 | 76.9 | 22.9 | 16.8% | 0.0% | 87.7 | 0.0% | +60.64% |
| Sai Parenterals Ltd | ₹0 Cr | ₹480.1 | 108.6 | 8.6 | 16.8% | 10.3% | 0.4 | 0.0% | 0.00% |
| SAKAR | ₹1,529 Cr | ₹786.75 | 61.1 | 5.1 | 10.0% | 14.2% | 0.2 | 0.0% | +93.02% |
| Sanofi India Ltd | ₹7,363 Cr | ₹3,191 | 23.8 | 9.8 | 0.0% | 413.1% | 0.0 | 0.0% | -30.49% |
| Sanofi Consumer Healthcare India Ltd | ₹11,059 Cr | ₹4,688.9 | 42.8 | 28.8 | 0.0% | 874.4% | 0.1 | 0.0% | +3.67% |
| Senores Pharmaceuticals Ltd | ₹5,202 Cr | ₹1,109.35 | 43.9 | 6.9 | 13.8% | 21.1% | 0.4 | 0.0% | +45.44% |
| Shalby Ltd | ₹1,690 Cr | ₹170.49 | 204.6 | 1.7 | 0.0% | 7.9% | 0.5 | 0.0% | -30.59% |
| Shilpa Medicare Ltd | ₹9,314 Cr | ₹474.65 | 42.2 | 3.8 | 0.0% | 12.0% | 0.2 | 0.0% | +19.15% |
| Sigachi Industries Ltd | ₹779 Cr | ₹20.39 | 0.0 | 1.5 | 0.0% | 21.4% | 0.3 | 0.0% | -45.06% |
| SMS Pharmaceuticals Ltd | ₹3,727 Cr | ₹425.85 | 39.8 | 4.9 | 0.0% | 15.9% | 0.4 | 0.0% | +38.24% |
| Solara Active Pharma Sciences Ltd | ₹2,704 Cr | ₹564.25 | 0.0 | 1.9 | -0.6% | 21.6% | 0.6 | 0.0% | +1.34% |
| Sun Pharma Advanced Research Company Ltd | ₹5,265 Cr | ₹180.33 | 0.0 | -15.3 | 0.0% | 0.0% | 0.0 | 0.0% | +21.84% |
| Strides Pharma Science Ltd | ₹10,613 Cr | ₹1,159.1 | 20.8 | 3.9 | 0.0% | 25.0% | 0.7 | 0.0% | +24.66% |
| Sudeep Pharma Ltd | ₹7,333 Cr | ₹668.2 | 43.7 | 9.8 | 0.0% | 30.5% | 0.2 | 0.0% | -16.13% |
| Supriya Lifescience Ltd | ₹5,505 Cr | ₹733.9 | 29.7 | 5.1 | 0.0% | 32.4% | 0.0 | 0.0% | -10.28% |
| Suven Life Sciences Ltd | ₹6,661 Cr | ₹269.52 | 0.0 | 20.0 | -78.8% | 0.0% | 0.0 | 0.0% | +34.35% |
| Syncom Formulations India Ltd-$ | ₹1,283 Cr | ₹14.26 | 18.7 | 3.3 | 0.0% | 21.5% | 0.0 | 0.0% | -15.05% |
| Take Solutions Ltd | ₹372 Cr | ₹28.14 | 0.0 | 14.5 | 0.0% | 0.0% | 0.0 | 0.0% | -1.62% |
| Themis Medicare Ltd | ₹912 Cr | ₹98.64 | 0.0 | 2.4 | 0.0% | 11.4% | 0.3 | 0.0% | -21.24% |
| TTK Healthcare Ltd | ₹1,267 Cr | ₹888.55 | 21.1 | 1.2 | 0.0% | 2.8% | 0.0 | 0.0% | -22.05% |
| Unichem Laboratories Ltd | ₹2,628 Cr | ₹367.15 | 8.9 | 1.1 | 0.0% | 4.9% | 0.2 | 0.0% | -22.08% |
| VAISHALI | ₹92 Cr | ₹6.99 | 117.8 | 1.4 | 0.0% | 11.3% | 0.2 | 0.0% | -44.13% |
| Valiant Laboratories Ltd | ₹408 Cr | ₹75.97 | 0.0 | 1.2 | -1.2% | -1.7% | 0.2 | 0.0% | -8.13% |
| Venus Remedies Ltd | ₹1,220 Cr | ₹1,030.55 | 16.0 | 2.1 | 0.0% | 23.7% | 0.0 | 0.0% | +80.55% |
| Vivimed Labs Ltd | ₹54 Cr | ₹6.55 | 0.0 | -1.1 | 0.0% | -41.5% | 0.0 | 0.0% | +27.68% |
| Viyash Scientific Ltd | ₹9,841 Cr | ₹247.54 | 87.4 | 7.0 | 0.0% | 20.0% | 0.6 | 0.0% | +22.88% |
| Wanbury Ltd | ₹902 Cr | ₹283 | 13.5 | 14.3 | 0.0% | 72.2% | 0.0 | 0.0% | +3.54% |
| Windlas Biotech Ltd | ₹1,647 Cr | ₹782.35 | 24.8 | 3.1 | 0.0% | 21.0% | 0.1 | 0.0% | -7.49% |
| Wockhardt Ltd | ₹25,463 Cr | ₹1,599.8 | 119.3 | 5.6 | 4.0% | 5.8% | 0.4 | 0.0% | +15.44% |
| Yatharth Hospital & Trauma Care Services Ltd | ₹7,790 Cr | ₹859.55 | 46.6 | 4.6 | 0.0% | 63.4% | 0.0 | 0.0% | +9.20% |
| Zim Laboratories Ltd | ₹530 Cr | ₹100.11 | 68.7 | 1.9 | 0.0% | 8.0% | 0.5 | 0.0% | +26.82% |
| ZOTA | ₹3,664 Cr | ₹1,216.3 | 0.0 | 11.7 | 0.0% | -32.7% | 0.6 | 0.0% | +27.91% |
| Tejnaksh Healthcare Ltd | ₹31 Cr | ₹14.4 | 22.1 | 1.2 | 8.3% | 0.0% | 0.0 | 0.0% | -34.25% |
| Hamps Bio Ltd | ₹23 Cr | ₹26.51 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | -47.89% |
| Muller & Phipps India Ltd | ₹15 Cr | ₹235 | 0.0 | -10.3 | -100.0% | 0.0% | 0.0 | 0.0% | -29.61% |
| Syschem India Ltd | ₹236 Cr | ₹49.53 | 32.5 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | +19.84% |
| Vivo Bio Tech Ltd | ₹61 Cr | ₹27 | 12.0 | 0.6 | 15.2% | 0.0% | 0.0 | 0.0% | -33.95% |
| Veerhealth Care Ltd | ₹45 Cr | ₹22.92 | 56.1 | 1.9 | 0.0% | 0.0% | 0.0 | 0.0% | +87.71% |
| Amwill Health Care Ltd | ₹65 Cr | ₹32.3 | 8.0 | 0.9 | 34.4% | 0.0% | 0.0 | 0.0% | -62.16% |
| Colinz Laboratories Ltd | ₹11 Cr | ₹42.01 | 23.0 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | -25.38% |
| Shanmuga Hospital Ltd | ₹52 Cr | ₹37.88 | 13.5 | 1.2 | 15.4% | 0.0% | 0.0 | 0.0% | +8.11% |
| Astonea Labs Ltd | ₹187 Cr | ₹178 | 40.4 | 3.2 | 26.3% | 0.0% | 0.0 | 0.0% | +31.22% |
| Ganga Pharmaceuticals Ltd | ₹7 Cr | ₹12 | 109.1 | 0.9 | 0.0% | 0.0% | 0.0 | 0.0% | -11.18% |
| Aashka Hospitals Ltd | ₹172 Cr | ₹73.5 | 70.7 | 1.7 | 13.0% | 0.0% | 0.0 | 0.0% | -33.12% |
| Fredun Pharmaceuticals Ltd | ₹1,295 Cr | ₹2,524.95 | 33.8 | 7.1 | 29.4% | 0.0% | 0.0 | 3.0% | +268.63% |
| Asston Pharmaceuticals Ltd | ₹65 Cr | ₹76.75 | 26.6 | 1.4 | 40.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Rekvina Laboratories Ltd | ₹25 Cr | ₹38.87 | 0.0 | -31.6 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Chennai Meenakshi Multispeciality Hospital Ltd-$ | ₹28 Cr | ₹37.8 | 0.0 | -11.1 | 0.0% | 0.0% | 0.0 | 0.0% | +20.0% |
| Medico Intercontinental Ltd | ₹23 Cr | ₹22.87 | 0.0 | 0.5 | 16.7% | 0.0% | 0.0 | 0.0% | -40.29% |
| Aptus Pharma Ltd | ₹317 Cr | ₹185 | 59.5 | 5.4 | 71.4% | 0.0% | 0.0 | 0.0% | 0.00% |
| Fabino Enterprises Ltd | ₹4 Cr | ₹20.31 | 0.0 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | -21.73% |
| Phaarmasia Ltd | ₹61 Cr | ₹88.65 | 3.4 | 5.7 | -50.0% | 0.0% | 0.0 | 0.0% | +210.51% |
| Achyut Healthcare Ltd | ₹119 Cr | ₹4.93 | 493.0 | 3.7 | 4.0% | 0.0% | 0.0 | 0.0% | +51.23% |
| Evoq Remedies Ltd | ₹8 Cr | ₹3.24 | 4.6 | 0.2 | 0.0% | 0.0% | 0.0 | 0.0% | +17.39% |
| Fortis Malar Hospitals Ltd | ₹101 Cr | ₹53.5 | 22.3 | 2.9 | 0.0% | 0.0% | 0.0 | 0.0% | -31.78% |
| Transgene Biotek Ltd | ₹24 Cr | ₹3.2 | 0.0 | 2.7 | 0.0% | 0.0% | 0.0 | 0.0% | -16.45% |
| Global Longlife Hospital and Research Ltd | ₹13 Cr | ₹12.83 | 0.0 | 0.5 | 0.0% | 0.0% | 0.0 | 0.0% | -60.46% |
| Astal Laboratories Ltd | ₹345 Cr | ₹78.6 | 11.5 | 2.0 | 42.9% | 0.0% | 0.0 | 0.0% | -6.26% |
| Dipna Pharmachem Ltd | ₹20 Cr | ₹7.5 | 8.7 | 0.3 | 3.7% | 0.0% | 0.0 | 0.0% | -56.45% |
| Desh Rakshak Aushdhalaya Ltd | ₹15 Cr | ₹30.13 | 35.7 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | -27.38% |
| Maitri Enterprises Ltd | ₹17 Cr | ₹43.6 | 150.0 | 3.9 | 0.0% | 0.0% | 0.0 | 0.0% | +83.19% |
| Hannah Joseph Hospital Ltd | ₹170 Cr | ₹75 | 20.7 | 2.2 | 16.3% | 0.0% | 0.0 | 0.0% | 0.00% |
| Accretion Nutraveda Ltd | ₹197 Cr | ₹272 | 75.1 | 4.6 | 100.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Trident Lifeline Ltd | ₹303 Cr | ₹253.5 | 20.4 | 3.6 | 37.5% | 0.0% | 0.0 | 0.0% | -5.46% |
| Parmax Pharma Ltd | ₹12 Cr | ₹31.17 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | -33.44% |
| Speciality Medicines Ltd | ₹237 Cr | ₹269.85 | 27.5 | 4.8 | 45.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Sanjivani Paranteral Ltd | ₹167 Cr | ₹139.05 | 20.7 | 3.8 | 0.0% | 0.0% | 0.0 | 37.0% | -40.67% |
| Genpharmasec Ltd | ₹64 Cr | ₹1.14 | 0.0 | 1.0 | 1.9% | 0.0% | 0.0 | 0.0% | -46.98% |
| Lactose India Ltd | ₹150 Cr | ₹124.15 | 30.9 | 2.4 | 12.8% | 0.0% | 0.0 | 0.0% | +28.65% |
| Gujarat Inject Kerala Ltd | ₹151 Cr | ₹103.5 | 171.7 | 13.7 | 6.7% | 0.0% | 0.0 | 0.0% | +436.27% |
| Gujarat Terce Laboratories Ltd | ₹28 Cr | ₹36.48 | 0.0 | 4.2 | -25.0% | 0.0% | 0.0 | 0.0% | -38.75% |
| Kabra Drugs Ltd | ₹59 Cr | ₹24.98 | 11.7 | 2.3 | -5.9% | 0.0% | 0.0 | 0.0% | +148.31% |
| One Global Service Provider Ltd | ₹872 Cr | ₹474 | 17.7 | 8.6 | 25.7% | 0.0% | 0.0 | 0.0% | +107.03% |
| CCME Global Ltd | ₹529 Cr | ₹116.9 | 0.0 | 13.0 | 80.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Smruthi Organics Ltd | ₹132 Cr | ₹115 | 28.7 | 1.8 | 5.8% | 0.0% | 0.0 | 130.0% | -1.63% |
| ANG Lifesciences India Ltd | ₹35 Cr | ₹26.88 | 0.0 | 0.6 | -22.6% | 0.0% | 0.0 | 0.0% | -5.58% |
| Panchsheel Organics Ltd | ₹168 Cr | ₹147 | 14.0 | 1.2 | 18.2% | 0.0% | 0.0 | 250.0% | +8.25% |
| Ishita Drugs & Industries Ltd | ₹23 Cr | ₹78 | 26.3 | 2.1 | 33.3% | 0.0% | 0.0 | 0.0% | -0.64% |
| Gennex Laboratories Ltd | ₹231 Cr | ₹10.95 | 13.0 | 1.1 | 22.8% | 0.0% | 0.0 | 0.0% | -16.41% |
| Family Care Hospitals Ltd | ₹18 Cr | ₹3.16 | 0.0 | 1.9 | -488.9% | 0.0% | 0.0 | 0.0% | -30.24% |
| Norris Medicines Ltd | ₹13 Cr | ₹12.81 | 0.0 | -0.8 | 0.0% | 0.0% | 0.0 | 0.0% | -25.26% |
| Unjha Formulations Ltd | ₹9 Cr | ₹19.33 | 8.6 | 2.1 | 0.0% | 0.0% | 0.0 | 0.0% | -19.22% |
| Asarfi Hospital Ltd | ₹384 Cr | ₹195.35 | 23.5 | 3.9 | 20.0% | 0.0% | 0.0 | 0.0% | +100.79% |
| Coral Laboratories Ltd | ₹163 Cr | ₹455.2 | 11.6 | 0.8 | 13.7% | 0.0% | 0.0 | 33.0% | -34.33% |
| Shree Ganesh Remedies Ltd | ₹739 Cr | ₹575.6 | 40.8 | 4.8 | 18.7% | 0.0% | 0.0 | 0.0% | -23.91% |
| Bacil Pharma Ltd | ₹82 Cr | ₹56.95 | 113.9 | 3.0 | 0.0% | 0.0% | 0.0 | 0.0% | +2.72% |
| KMC Speciality Hospitals (India) Ltd | ₹1,545 Cr | ₹94.73 | 42.3 | 8.5 | 12.7% | 0.0% | 0.0 | 0.0% | +38.01% |
| Shelter Pharma Ltd | ₹53 Cr | ₹31.8 | 5.9 | 0.6 | 23.3% | 0.0% | 0.0 | 110.0% | -16.88% |
| Sharma East India Hospitals & Medical Research Ltd | ₹33 Cr | ₹102 | 28.3 | 2.6 | 9.1% | 0.0% | 0.0 | 0.0% | +30.77% |
| Pharmaids Pharmaceuticals Ltd | ₹106 Cr | ₹30.11 | 0.0 | 2.1 | -137.5% | 0.0% | 0.0 | 0.0% | -54.36% |
| Adline Chem Lab Ltd | ₹8 Cr | ₹13.05 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | -5.84% |
| Beryl Drugs Ltd | ₹11 Cr | ₹21.15 | 705.0 | 1.0 | 11.1% | 0.0% | 0.0 | 0.0% | +7.96% |
| Shukra Pharmaceuticals Ltd | ₹1,375 Cr | ₹31.4 | 62.8 | 22.7 | 17.2% | 0.0% | 0.0 | 3.0% | +147.44% |
| Oxygenta Pharmaceutical Ltd | ₹205 Cr | ₹55.54 | 0.0 | -5.6 | 0.0% | 0.0% | 0.0 | 0.0% | -34.67% |
| Welcure Drugs & Pharmaceuticals Ltd | ₹36 Cr | ₹0.29 | 1.3 | 0.3 | 1.8% | 0.0% | 0.0 | 0.0% | -71.39% |
| Bharat Immunologicals & Biologicals Corporation Ltd-$ | ₹75 Cr | ₹17.38 | 0.0 | 1.0 | 0.0% | 0.0% | 0.0 | 0.0% | -23.17% |
| KK Shah Hospitals Ltd | ₹29 Cr | ₹42 | 0.0 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Sandu Pharmaceuticals Ltd | ₹37 Cr | ₹38.39 | 18.2 | 0.9 | 10.0% | 0.0% | 0.0 | 208.0% | -25.47% |
| Looks Health Services Ltd | ₹6 Cr | ₹6 | 30.0 | 0.3 | 0.0% | 0.0% | 0.0 | 0.0% | +22.7% |
| Vista Pharmaceuticals Ltd | ₹45 Cr | ₹7.3 | 0.0 | 1.0 | 0.0% | 0.0% | 0.0 | 0.0% | -30.48% |
| Titan Biotech Ltd | ₹1,871 Cr | ₹452.9 | 68.9 | 11.2 | 15.3% | 0.0% | 0.0 | 9.0% | +391.91% |
| Jenburkt Pharmaceuticals Ltd | ₹529 Cr | ₹1,199.6 | 16.3 | 2.9 | 19.3% | 0.0% | 0.0 | 168.0% | +16.07% |
| Bharat Parenterals Ltd | ₹863 Cr | ₹1,252.05 | 0.0 | 2.0 | -7.1% | 0.0% | 0.0 | 8.0% | +19.68% |
| Zenotech Laboratories Ltd | ₹275 Cr | ₹43.52 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | -23.68% |
| Hindustan Bio Sciences Ltd | ₹9 Cr | ₹8.53 | 59.1 | 10.1 | 0.0% | 0.0% | 0.0 | 0.0% | +11.5% |
| Parnax Lab Ltd | ₹186 Cr | ₹157.1 | 14.8 | 2.1 | 18.2% | 0.0% | 0.0 | 0.0% | +59.09% |
| Decipher Labs Ltd | ₹8 Cr | ₹7.5 | 0.0 | 0.4 | -38.5% | 0.0% | 0.0 | 0.0% | -36.6% |
| Emmessar Biotech & Nutrition Ltd | ₹13 Cr | ₹25.65 | 40.1 | 10.8 | 0.0% | 0.0% | 0.0 | 0.0% | -24.54% |
| Everest Organics Ltd | ₹251 Cr | ₹258.3 | 49.0 | 3.5 | -2.4% | 0.0% | 0.0 | 0.0% | -36.51% |
| BDH Industries Ltd | ₹214 Cr | ₹371.8 | 20.5 | 3.0 | 17.3% | 0.0% | 0.0 | 121.0% | +40.17% |
| Novelix Pharmaceuticals Ltd | ₹112 Cr | ₹58.5 | 47.1 | 3.0 | 0.0% | 0.0% | 0.0 | 0.0% | +142.24% |
| Royal Sense Ltd | ₹75 Cr | ₹140 | 11.8 | 2.1 | 46.2% | 0.0% | 0.0 | 0.0% | -40.37% |
| Sunil Healthcare Ltd | ₹65 Cr | ₹62.24 | 22.8 | 1.0 | -2.0% | 0.0% | 0.0 | 0.0% | -12.38% |
| Denis Chem Lab Ltd | ₹100 Cr | ₹70 | 11.5 | 0.0 | 15.1% | 0.0% | 0.0 | 208.0% | -30.14% |
| Broach Lifecare Hospital Ltd | ₹10 Cr | ₹16 | 20.8 | 0.5 | 14.3% | 0.0% | 0.0 | 0.0% | 0.00% |
| Deccan Health Care Ltd | ₹31 Cr | ₹12.67 | 13.8 | 0.3 | 3.0% | 0.0% | 0.0 | 0.0% | -30.38% |
| Jeevan Scientific Technology Ltd | ₹167 Cr | ₹83 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | +100.68% |
| Nexus Surgical And Medicare Ltd | ₹12 Cr | ₹19.03 | 20.5 | 8.6 | 0.0% | 0.0% | 0.0 | 0.0% | +21.6% |
| Mercury Laboratories Ltd | ₹91 Cr | ₹760.2 | 19.3 | 1.6 | 30.0% | 0.0% | 0.0 | 46.0% | -9.63% |
| Concord Drugs Ltd | ₹107 Cr | ₹81.06 | 184.1 | 2.4 | 0.0% | 0.0% | 0.0 | 0.0% | +163.95% |
| Star Source Multi Trade Ltd | ₹17 Cr | ₹119.9 | 0.0 | 12.1 | 0.0% | 0.0% | 0.0 | 0.0% | -10.49% |
| Cian Healthcare Ltd | ₹1 Cr | ₹8.26 | 0.0 | 0.0 | -104.0% | 0.0% | 0.0 | 0.0% | -84.89% |
| Genomic Valley Biotech Ltd | ₹8 Cr | ₹25.4 | 0.0 | 2.1 | 0.0% | 0.0% | 0.0 | 0.0% | -57.86% |
| Valencia Nutrition Ltd | ₹121 Cr | ₹70 | 34.7 | 3.2 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Chandra Bhagat Pharma Ltd | ₹25 Cr | ₹33 | 39.8 | 0.8 | 4.8% | 0.0% | 0.0 | 0.0% | 0.00% |
| Vivanza Biosciences Ltd | ₹8 Cr | ₹1.83 | 0.0 | 1.7 | -25.0% | 0.0% | 0.0 | 0.0% | -12.44% |
| Tyche Industries Ltd | ₹139 Cr | ₹135.3 | 20.3 | 1.0 | 9.3% | 0.0% | 0.0 | 222.0% | -8.36% |
| Kerala Ayurveda Ltd | ₹268 Cr | ₹207.8 | 0.0 | 33.1 | -116.7% | 0.0% | 0.0 | 0.0% | -46.11% |
| Brawn Biotech Ltd | ₹6 Cr | ₹21.6 | 0.0 | 1.7 | -200.0% | 0.0% | 0.0 | 0.0% | +17.07% |
| Auro Laboratories Ltd | ₹167 Cr | ₹275.8 | 51.5 | 3.8 | 4.8% | 0.0% | 0.0 | 0.0% | +7.65% |
| Kimia Biosciences Ltd | ₹169 Cr | ₹36.39 | 0.0 | 14.9 | 0.0% | 0.0% | 311.5 | 0.0% | -11.09% |
| Godavari Drugs Ltd | ₹130 Cr | ₹126.75 | 0.0 | 2.1 | 12.5% | 0.0% | 0.0 | 0.0% | +34.87% |
| Vikram Thermo India Ltd | ₹477 Cr | ₹148.6 | 14.0 | 3.5 | 7.1% | 0.0% | 0.0 | 66.0% | -16.07% |
| Zenith Healthcare Ltd | ₹16 Cr | ₹3.25 | 38.1 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | -28.57% |
| Zenlabs Ethica Ltd | ₹19 Cr | ₹30.38 | 0.0 | 1.7 | 0.0% | 0.0% | 0.0 | 0.0% | -4.76% |
| Makers Laboratories Ltd | ₹94 Cr | ₹159.7 | 77.7 | 1.3 | 18.4% | 0.0% | 0.0 | 0.0% | +14.07% |
| NG Industries Ltd-$ | ₹42 Cr | ₹128 | 0.0 | 1.1 | 22.9% | 0.0% | 0.0 | 277.0% | -22.38% |
| Venmax Drugs and Pharmaceuticals Ltd | ₹29 Cr | ₹24.7 | 15.5 | 1.7 | 0.0% | 0.0% | 0.0 | 0.0% | -12.32% |
| Dhanvantri Jeevan Rekha Ltd | ₹8 Cr | ₹19.7 | 65.1 | 0.8 | 10.0% | 0.0% | 0.0 | 0.0% | -0.25% |
| Shamrock Industrial Company Ltd | ₹12 Cr | ₹22.44 | 0.0 | 10.5 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Soni Medicare Ltd | ₹31 Cr | ₹73 | 0.0 | 354.4 | 0.0% | 0.0% | 0.0 | 0.0% | +0.55% |
| Kobo Biotech Ltd-$ | ₹6 Cr | ₹3.11 | 0.0 | -0.1 | -20.8% | 0.0% | 0.0 | 0.0% | +14.76% |
| Advik Laboratories Ltd | ₹3 Cr | ₹1.73 | 0.0 | 4.9 | -100.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Avi Products India Ltd | ₹15 Cr | ₹45.28 | 0.0 | 2.4 | 0.0% | 0.0% | 0.0 | 0.0% | +74.15% |
| Bijoy Hans Ltd | ₹278 Cr | ₹57.99 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | +152.13% |
| Dhruv Wellness Ltd | ₹5 Cr | ₹4.58 | 0.0 | -0.3 | 0.0% | 0.0% | 0.0 | 0.0% | -26.13% |
India is the pharmacy of the world, supplying 20% of global generic medicine volume. The sector is bifurcated — domestic formulations offer stable growth (10-12%) with high margins, while US generics face pricing erosion but massive volume opportunity. CDMO (Contract Development and Manufacturing) has emerged as a structural growth driver post-COVID.
Key focus areas: domestic chronic therapy mix, specialty pipeline in US, Biosimilar approvals, and FDA compliance track record. Margins vary widely — specialty players earn 25-30% EBITDA margins vs. commodity generics at 12-18%.
Zero or low debt is common, making the sector defensive. Valuations are elevated at 30-40x PE for quality names.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.